They discovered two subgroups: VEGFA + SPP1 +, which is significantly overexpressed in renal cancer and linked to tumor angiogenesis and growth, and HLA-DR + CD74 +, which is present in renal cancer and contributes to antitumor immunity by activating T cells. Here, VEGFA is linked to neoplasm.